This study on the pharmacological properties of KP10 and its analogs illuminates the contextual variability in the efficacy of kisspeptins across different cancer types, revealing metastasis-suppressing effects in various models but also contradictory roles, such as in hepatocellular carcinoma [41]. This evidence concerns the gene KISS1 and cancer.